These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Activities of BMS 284756 (T-3811) against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from SENTRY antimicrobial surveillance program medical centers in Latin America (1999). Gales A, Sader H, Jones RN, SENTRY Participants Group (Latin America). Antimicrob Agents Chemother; 2001 May; 45(5):1463-6. PubMed ID: 11302811 [Abstract] [Full Text] [Related]
6. Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98). Sader HS, Gales AC, Granacher TD, Pfaller MA, Jones RN, SENTRY Study Group (Latin America). Braz J Infect Dis; 2000 Oct; 4(5):245-54. PubMed ID: 11063556 [Abstract] [Full Text] [Related]
9. Comparative activity of garenoxacin (BMS 284756), a novel desfluoroquinolone, tested against 8,331 isolates from community-acquired respiratory tract infections: North American results from the SENTRY Antimicrobial Surveillance Program (1999-2001). Jones RN, Biedenbach DJ. Diagn Microbiol Infect Dis; 2003 Apr; 45(4):273-8. PubMed ID: 12729999 [Abstract] [Full Text] [Related]
10. Prevalence of antimicrobial resistance in Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis and Streptococcus pyogenes: results of a multicentre study in Turkey. Gür D, Ozalp M, Sümerkan B, Kaygusuz A, Töreci K, Köksal I, Over U, Söyletir G. Int J Antimicrob Agents; 2002 Mar; 19(3):207-11. PubMed ID: 11932143 [Abstract] [Full Text] [Related]
11. Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods. Morrissey I, Robbins M, Viljoen L, Brown DF. J Antimicrob Chemother; 2005 Feb; 55(2):200-8. PubMed ID: 15649996 [Abstract] [Full Text] [Related]
12. Antimicrobial susceptibility of lower respiratory tract pathogens in Great Britain and Ireland 1999-2001 related to demographic and geographical factors: the BSAC Respiratory Resistance Surveillance Programme. Reynolds R, Shackcloth J, Felmingham D, MacGowan A, BSAC Extended Working Party on Respiratory Resistance Surveillance. J Antimicrob Chemother; 2003 Dec; 52(6):931-43. PubMed ID: 14585865 [Abstract] [Full Text] [Related]
17. Antimicrobial activity of advanced-spectrum fluoroquinolones tested against more than 2000 contemporary bacterial isolates of species causing community-acquired respiratory tract infections in the United States (1999). Deshpande LM, Jones RN. Diagn Microbiol Infect Dis; 2000 Jun; 37(2):139-42. PubMed ID: 10863108 [Abstract] [Full Text] [Related]
19. Sensitivity to sparfloxacin and other antibiotics, of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis strains isolated from adult patients with community-acquired lower respiratory tract infections: a European multicentre study. SPAR Study Group. Surveillance Programme of Antibiotic Resistance. Richard MP, Aguado AG, Mattina R, Marre R. J Antimicrob Chemother; 1998 Feb; 41(2):207-14. PubMed ID: 9533462 [Abstract] [Full Text] [Related]
20. [Serotype distribution and drug resistance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from nasopharynx of Uygur children]. Tian HL, Shi W, Zhou HF, Yuan L, Yao KH, Rexiati D, Xu AM. Zhonghua Er Ke Za Zhi; 2018 Apr 02; 56(4):279-283. PubMed ID: 29614568 [Abstract] [Full Text] [Related] Page: [Next] [New Search]